217 related articles for article (PubMed ID: 8272312)
1. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial.
Thorp JA; Parriott J; Ferrette-Smith D; Meyer BA; Cohen GR; Johnson J
Obstet Gynecol; 1994 Jan; 83(1):70-6. PubMed ID: 8272312
[TBL] [Abstract][Full Text] [Related]
2. Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation.
Thorp JA; Ferrette-Smith D; Gaston LA; Johnson J; Yeast JD; Meyer B
Obstet Gynecol; 1995 Jul; 86(1):1-8. PubMed ID: 7784000
[TBL] [Abstract][Full Text] [Related]
3. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation.
Liu J; Wang Q; Zhao JH; Chen YH; Qin GL
J Trop Pediatr; 2006 Oct; 52(5):355-9. PubMed ID: 16751657
[TBL] [Abstract][Full Text] [Related]
4. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
[TBL] [Abstract][Full Text] [Related]
5. Use of prenatal phenobarbital in the prevention of subependymal/intraventricular hemorrhage in premature infants.
Arroyo-Cabrales LM; Garza-Morales S; Hernández-Peláez G
Arch Med Res; 1998; 29(3):247-51. PubMed ID: 9775459
[TBL] [Abstract][Full Text] [Related]
6. Does perinatal phenobarbital exposure affect developmental outcome at age 2?
Thorp JA; O'Connor M; Jones AM; Hoffman EL; Belden B
Am J Perinatol; 1999; 16(2):51-60. PubMed ID: 10355910
[TBL] [Abstract][Full Text] [Related]
7. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants.
Kazzi NJ; Ilagan NB; Liang KC; Kazzi GM; Poland RL; Grietsell LA; Fujii Y; Brans YW
Pediatrics; 1989 Dec; 84(6):1045-50. PubMed ID: 2587133
[TBL] [Abstract][Full Text] [Related]
8. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial.
De Lia JE; Billman D
Obstet Gynecol; 1994 Jun; 83(6):1067-9. PubMed ID: 8190426
[No Abstract] [Full Text] [Related]
9. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
Liu J; Wang Q; Gao F; He JW; Zhao JH
J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes.
Vermillion ST; Soper DE; Bland ML; Newman RB
Am J Obstet Gynecol; 2000 Oct; 183(4):925-9. PubMed ID: 11035339
[TBL] [Abstract][Full Text] [Related]
11. Maternally administered antenatal vitamin K1: effect on neonatal prothrombin activity, partial thromboplastin time, and intraventricular hemorrhage.
Pomerance JJ; Teal JG; Gogolok JF; Brown S; Stewart ME
Obstet Gynecol; 1987 Aug; 70(2):235-41. PubMed ID: 3601288
[TBL] [Abstract][Full Text] [Related]
12. Routine administration of phenobarbital for the prevention of intraventricular hemorrhage in premature infants: five years' experience.
Chen HJ; Roloff DW
J Perinatol; 1994; 14(1):15-22. PubMed ID: 8169672
[TBL] [Abstract][Full Text] [Related]
13. Effect of prophylactic phenobarbital on intraventricular hemorrhage in high-risk infants.
Bedard MP; Shankaran S; Slovis TL; Pantoja A; Dayal B; Poland RL
Pediatrics; 1984 Apr; 73(4):435-9. PubMed ID: 6369238
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of phenobarbital usage for prevention of intraventricular hemorrhage in premature infants: factors related to variation in outcome.
Tholl DA; Miller TQ; Henderson WG; Myers TF
Clin Trials Metaanal; 1994 Oct; 29(2-3):177-90. PubMed ID: 10150225
[TBL] [Abstract][Full Text] [Related]
15. Effect of phenobarbital on motor activity and intraventricular hemorrhage in preterm infants with respiratory disease weighing less than 1500 grams.
Porter FL; Marshall RE; Moore JA; Miller RH
Am J Perinatol; 1985 Apr; 2(2):63-6. PubMed ID: 4096759
[TBL] [Abstract][Full Text] [Related]
16. Intraventricular hemorrhage and vitamin E in the very low-birth-weight infant: evidence for efficacy of early intramuscular vitamin E administration.
Speer ME; Blifeld C; Rudolph AJ; Chadda P; Holbein ME; Hittner HM
Pediatrics; 1984 Dec; 74(6):1107-12. PubMed ID: 6504632
[TBL] [Abstract][Full Text] [Related]
17. Antenatal phenobarbital for prevention of intraventricular hemorrhage in preterm infants.
Klinger G; Koren G
Can Fam Physician; 2000 Jun; 46():1285-7. PubMed ID: 10907564
[TBL] [Abstract][Full Text] [Related]
18. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].
Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H
Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029
[TBL] [Abstract][Full Text] [Related]
19. Neonatal intracranial hemorrhage and phenobarbital.
Kuban KC; Leviton A; Krishnamoorthy KS; Brown ER; Teele RL; Baglivo JA; Sullivan KF; Huff KR; White S; Cleveland RH
Pediatrics; 1986 Apr; 77(4):443-50. PubMed ID: 3515304
[TBL] [Abstract][Full Text] [Related]
20. The use of indomethacin for the prevention of intraventricular brain hemorrhage in high-risk neonates.
Al-Shawaf EM; Al-Alaiyan SA; Aqeel AY; Gamal MH
Saudi Med J; 2000 Mar; 21(3):274-7. PubMed ID: 11533797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
